Aptevo Therapeutics Inc 의견 예상치 (APVO) - Investing.com
Aptevo Therapeutics Inc 의견 예상치 (APVO) - Investing.com
Jan 16, 2019
investing.com
Aptevo Therapeutics CEO Marvin L. White on the Future of Cancer Immunotherapy | Aptevo Therapeutics Inc
Aptevo Therapeutics CEO Marvin L. White on the Future of Cancer Im…
10 months ago
linkedin.com
Aptevo Therapeutics Inc. publie ses résultats financiers pour le troisième trimestre et les neuf premiers mois clos le 30 septembre 2025
Aptevo Therapeutics Inc. publie ses résultats financiers pour le troisiè…
1 month ago
zonebourse.com
Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation
Aptevo Therapeutics Provides Program Update for Bispecific AP…
2 months ago
kron4.com
Aptevo Therapeutics: Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers
Aptevo Therapeutics: Aptevo Expands Differentiated CD3 Portfo…
6 months ago
finanznachrichten.de
Aptevo Therapeutics: Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm
Aptevo Therapeutics: Aptevo Highlights the Potential of the Co…
Nov 22, 2024
finanznachrichten.de
Aptevo Therapeutics: Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation
Aptevo Therapeutics: Proving the Concept: Aptevo Technology, Pip…
Nov 26, 2024
finanznachrichten.de
Aptevo Therapeutics Presenting at The Protein & Antibody Engineeri…
May 14, 2024
finanznachrichten.de
Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part …
6 months ago
finanznachrichten.de
Aptevo Therapeutics: First-in-Class Bispecific Antibody, ALG.APV-527…
Nov 11, 2024
finanznachrichten.de
Aptevo Therapeutics: RAINIER Trial Data Update: Two Additional AML …
9 months ago
finanznachrichten.de
1:28
15K views · 194 reactions | Regeneron Pharmaceuticals said i…
5K views1 week ago
FacebookReuters
Juno Therapeutics sued on securities fraud allegations followi…
Aug 16, 2016
geekwire.com
Stock Alert: Aptevo Up 45%; To Get Royalty Payment From Pfizer For …
Jun 25, 2020
nasdaq.com
Solvonis Therapeutics CEO on name change, Awakn acquisition …
11 months ago
proactiveinvestors.co.uk
With New Cash Aptevo Goes It Alone on Prostate Drug, Shares U…
Sep 1, 2017
thestreet.com
Sorrento Therapeutics Sued Over ‘False' Claims About Finding ‘Cur…
Jun 12, 2020
nbcsandiego.com
Solvonis Therapeutics engages PharmaVentures to support key A…
9 months ago
proactiveinvestors.co.uk
Solvonis Therapeutics eyes completion of Awakn acquisition f…
8 months ago
proactiveinvestors.co.uk
Solvonis Therapeutics CEO Anthony Tennyson on merits of acquisitio…
10 months ago
proactiveinvestors.co.uk
12:16
앱티보 테라퓨틱스 Aptevo Therapeutics Inc. (APVO)기업 분석
441 views3 months ago
YouTube모여라 서학개미
50:10
Peptides, Longevity & Real Anti-Aging Medicine | Dr. Jonathann Kuo
2.6K views1 month ago
YouTubeDr. Rossi DERM MD
3:10
$APVO Stock Analysis: No News Float Runner Breaks Out 🔥📈
83 views2 months ago
YouTubeCNM
2:48
APVO Stock Analysis (Aptevo Therapeutics Stock) September 18…
23 views3 months ago
YouTubeFinance Podcast with Arman Nikoghosyan
1:38
Oct 7 TMQ APVO TELO
109 views2 months ago
YouTubeHomeschoolstocks
0:14
Lovely and Lifted!
1.2K views1 week ago
YouTubeAAFE
3:00
盤點因質量太好差點倒閉的六大國產製造，你家用過哪個 #萬萬沒想到 # …
718.1K views2 weeks ago
YouTube青山探知
Sorrento Therapeutics CEO talks moving Abivertinib into Phase 2 tr…
Jul 20, 2020
CNBC
APVO Stock THURSDAY UPDATE! (The Exact Answer) Aptevo Thera…
182 views6 months ago
YouTubemr. sicko Trading
Axovant largest biotech IPO ever
Jun 11, 2015
CNBCBob Pisani
See more videos
Static thumbnail place holder